Literature DB >> 24690341

An evaluation on management of carotid body tumour (CBT). A twelve years experience.

G Boscarino, E Parente, F Minelli, Alberto Ferrante, F Snider.   

Abstract

Objectives. Carotid Body Tumor (CBT) is a rare lesion of the neuroendocrine system but it is the most common form of head and neck paraganglioma (PGL). Our objective is to discuss the optimal management of these lesions to provide the best outcome of patients treated by surgical resection. Patients and Methods. A retrospective evaluation was obtained by review of the records of 20 patients with 26 CBT treated at our institution between 2000 and 2012. Primary tumor characteristics, diagnostic protocols, surgical treatment, short and long-term outcomes were collected and analyzed. Results. A total of 26 CBTs resections were performed on 20 patients; the age range was 21-89 years. There was a female prevalence (14 women-80% and 6 men-20%). Familial cases occurred in 6 patients (30%); of these, 3 patients had bilateral lesions and 1 patient multiple paragangliomas. In all cases no lymph node metastasis was found. All lesions were grouped into three groups according to the latero-lateral diameter: Group I < 3 cm; Group II 3<>5cm; Group III >5cm. All patients were managed by surgical resection of the CBT. There were no operative deaths. Overall we found transitory neurological impairment in 15,3% and permanent neurological deficit in 7,6% of cases. No complications occurred in all resections of Group I tumors. In Group II only 1 resection was followed by dysphonia by recurrent nerve palsy (after vagal nerve en-bloc resection). In Group III only 1 resection was followed by permanent vagus nerve palsy. Conclusions. Surgical removal of the tumor is the only treatment that can ensure a complete eradication of the disease. Family screening is of great importance in patients with hereditary forms. Careful preoperative planning of surgical procedure by integrated diagnostic imaging and a full mastery of the surgical technique can minimize the risk of the most common postoperative complications. Lifelong follow-up is mandatory to make early diagnosis of recurrent disease.

Entities:  

Mesh:

Year:  2014        PMID: 24690341      PMCID: PMC4321583     

Source DB:  PubMed          Journal:  G Chir        ISSN: 0391-9005


  19 in total

Review 1.  Carotid body tumor in a 13-year-old child: Case report and review of the literature.

Authors:  George S Georgiadis; Miltos K Lazarides; Aggelos Tsalkidis; Paraskevi Argyropoulou; Alexandra Giatromanolaki
Journal:  J Vasc Surg       Date:  2008-02-14       Impact factor: 4.268

2.  Preoperative embolization of carotid body tumors: when is it appropriate?

Authors:  V R Litle; L M Reilly; T K Ramos
Journal:  Ann Vasc Surg       Date:  1996-09       Impact factor: 1.466

3.  [Resection of carotid body tumor under interrupted block of common carotid artery].

Authors:  Mu-yun Jia; Hao-fu Wang; Jian Sun; Ning-yi Li; Bao-dong Zhao; Wei Shang
Journal:  Shanghai Kou Qiang Yi Xue       Date:  2005-04

4.  Risk factors for stroke during surgery for carotid body tumors.

Authors:  Jun Gyo Gwon; Tae-Won Kwon; Hyangkyoung Kim; Yong-Pil Cho
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

5.  A multicenter review of carotid body tumour management.

Authors:  M S Sajid; G Hamilton; D M Baker
Journal:  Eur J Vasc Endovasc Surg       Date:  2007-04-02       Impact factor: 7.069

6.  [Familial paragangliomas of the neck: integrated imaging and the planning of family screening].

Authors:  A Carriero; G Rossner; A Nuzzo; L Basilico; L Bonomo
Journal:  Radiol Med       Date:  1990-04       Impact factor: 3.469

7.  Malignant carotid body tumor: a case report.

Authors:  A Dias Da Silva; S O'Donnell; D Gillespie; J Goff; C Shriver; N Rich
Journal:  J Vasc Surg       Date:  2000-10       Impact factor: 4.268

8.  Carotid body tumors: a 40-year study.

Authors:  H W Farr
Journal:  CA Cancer J Clin       Date:  1980 Sep-Oct       Impact factor: 508.702

9.  Carotid body tumour resection with LigaSure device.

Authors:  Kuauhyama Luna-Ortiz; Verónica Villavicencio-Valencia; Tania Carmona-Luna; Ana María Cano-Valdez; Angel Herrera Gómez
Journal:  Acta Otorrinolaringol Esp       Date:  2009-10-08

10.  Diagnosis and surgical treatment of carotid body tumor: A report of 18 cases.

Authors:  Dan Ma; Min Liu; Hua Yang; Xiaogan Ma; Chaojun Zhang
Journal:  J Cardiovasc Dis Res       Date:  2010-07
View more
  5 in total

1.  Imaging criteria to predict Shamblin group in carotid body tumors - revisited.

Authors:  Anitha Jasper; Suraj Mammen; Mahasampath S Gowri; Shyamkumar N Keshava; Dheepak Selvaraj
Journal:  Diagn Interv Radiol       Date:  2021-05       Impact factor: 2.630

2.  Multidisciplinary Management of Carotid Body Tumors in a Tertiary Urban Institution.

Authors:  George Galyfos; Ioannis Stamatatos; Stavros Kerasidis; Ioannis Stefanidis; Sotirios Giannakakis; Georgios Kastrisios; Georgios Geropapas; Gerasimos Papacharalampous; Chrisostomos Maltezos
Journal:  Int J Vasc Med       Date:  2015-12-09

3.  Hepatic metastatic paraganglioma 12 years after retroperitoneal paraganglioma resection: a case report.

Authors:  Zhao-Ru Dong; Yan-Ni Xia; Yue-Yi Zhao; Rui Wu; Kai-Xuan Liu; Kai Shi; Lun-Jie Yan; Cheng-Yu Yao; Yu-Chuan Yan; Tao Li
Journal:  BMC Gastroenterol       Date:  2019-08-08       Impact factor: 3.067

4.  Assessment of Carotid Body Tumors by Superb Microvascular Imaging of Feeding Arteries During Preoperative Evaluation.

Authors:  Luying Gao; Xiaoyan Zhang; Yuxin Jiang; Hongyan Wang; Yuehong Zheng; Wanying Li; Jianchu Li; Bo Zhang
Journal:  Front Surg       Date:  2022-04-26

5.  Comparison of Contrast-Enhanced Ultrasonography to Color Doppler Ultrasound in Evaluation of Carotid Body Tumors.

Authors:  Guangchao Gu; Xiaoyan Zhang; Junyue Shen; Shayan Gulidanna; Qiong Gao; Jiang Shao; Bao Liu; Bo Zhang; Yuehong Zheng
Journal:  Front Oncol       Date:  2022-04-11       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.